Abstract. Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide, and the highest incidence rates are reported in East Asia. We previously showed that SNAIL is upregulated in HCC tissues. In the present study, we aimed to investigate RNA interferencemediated targeting of SNAIL on the growth of HepG2 cells. We constructed three RNA interference plasmids targeting the SNAIL gene and selected the most efficient shRNA expression cassette. After the lentivirus (LV)-SNAIL small interfering (si)RNA vector was transfected into the HepG2 cell line, cell proliferation was measured using the MTT assay. E-cadherin mRNA and protein expression levels were examined by quantitative PCR and western blotting, respectively. We successfully constructed an LV-SNAIL siRNA lentiviral vector and demonstrated that it suppressed the expression of the SNAIL gene in HepG2 cells. RNA interference of SNAIL by the LV-SNAIL siRNA construct significantly inhibited the growth of HepG2 cells, in addition to significantly increasing E-cadherin mRNA and protein expression. Our findings strongly suggest that SNAIL and E-cadherin play a significant role in HCC progression, and exhibit a negative correlation. Furthermore, the expression of E-cadherin may be responsible for the reduced proliferation and survival of HepG2 cells. Thus, the SNAIL signaling pathway may provide a novel therapeutic target for the treatment of HCC.
Introduction
Hepatocellular carcinoma (HCC) is a common, highly invasive malignant tumor associated with a high mortality rate. It is the third leading cause of cancer-related mortality worldwide (1) and the highest incidence rates are reported in East Asia (2, 3) . Recurrence, metastasis and the development of new primary tumors are the most common causes of mortality among patients with HCC (4) . The mainstay of therapy is surgical resection, however, only 10-20% of patients are suitable for surgical treatment (5) . In addition, recent developments in genomic technologies have enabled the study of molecular aberrations and deregulations directly from patient specimens in a comprehensive manner (6) . However, the target gene locus associated with genomic therapy remains unelucidated. Thus, given the single means of treatment and the lack of a targeted locus, there is an urgent need for developing novel treatments that can prevent the early invasion and metastasis of HCC and for surveying new molecular-targeted sites that offer the possibility for the effective development of gene therapy.
Epithelial to mesenchymal transition (EMT), which converts epithelial cells into migratory mesenchymal cells, is crucial for embryonic development. It is characterized by upregulation of extracellular matrix components, loss of intercellular cohesion, an increased rate of cellular migration and invasion, as well as increased resistance to apoptosis. Recently, EMT has emerged as a pivotal event in the development of invasion and metastasis associated with cancer progression (7) . This type of transition involves a decrease in E-cadherin expression and gain of vimentin expression, leading to increased cell migration, invasion and tumorigenicity (8) . Downregulation of E-cadherin is a major event in EMT. E-cadherin, which is a key cadherin, plays a major role in the establishment and maintenance of intercellular adhesion, cell polarity and tissue architecture (9) . Currently, there is substantial evidence that functional perturbation of E-cadherin expression during the process of EMT occurs at the transcriptional level. According to studies, numerous transcription factors have been associated with the regulation of EMT, including SNAIL (10), Zeb1 (11), Zeb (2), Twist1 (12) and Slug (13) . Among these regulators, SNAIL is a prominent inducer of EMT which strongly suppresses E-cadherin expression (14) .
SNAIL is a well-known zinc finger (ZF) transcriptional repressor which is essential during embryonic development (15) . Numerous studies have shown that SNAIL is significantly upregulated in a variety of malignant tumors. There is also evidence that SNAIL enhances invasive and metastatic potential, and the malignant tumors exibiting SNAIL upregulation are prone to distant metastasis, deep invasion and poor prognosis. (17) . RNAi has emerged as a powerful technique through which to downregulate the expression of specific genes in cells and in animals. Among the shRNA delivery mechanisms, viral vectors, and in particular lentiviral vectors, are capable of specific, highly stable and functional silencing of gene expression in a variety of human cells including primary non-dividing cells (18) . In the present study, we used a lentiviral vector, carrying SNAIL shRNA for transfection into HepG2 cells in order to knock down the expression of the target gene SNAIL. Through gene expression analysis at the mRNA and protein levels, we observed that knockdown of SNAIL led to the activation of E-cadherin expression, resulting in reduced cell proliferation and viability of HCC cells. Thus, targeted inactivation of SNAIL may provide a novel therapeutic strategy for HCC patients expressing this gene.
Materials and methods
Construction of the pGenesil-SNAIL siRNA. Three pairs of shRNAs were used for screening the most effective downregulation of the gene fragment. In the enzyme site of the vector pGenesil-1, three coding regions corresponding to the target human SNAIL (NM_005985), starting at positions 122, 150 and 518 in the sequence were selected as siRNA target sequences under the guide of the siRNA designing software. The target shRNA oligonucleotides were annealed and ligated with the siRNAs, and the pGenesil-1 vector was cleaved by BamHI and HindIII, and then the products were recovered and purified. shRNA oligonucleotide fragment and the pGenesil-1 vector were ligated, and the recombinant plasmids were named pGenesil-SNAIL shRNA-1-3. Next, pGenesil-GFP-SNAIL shRNAs were transfected into HepG2 cells, respectively, using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). The most effective siRNA, by screening using analysis of the SNAIL mRNA and protein levels in HepG2 cells, was detected and used for subsequent experiments. (Fig. 1) . The most effective shRNA expression cassette was selected and cut off by BamHI and MluI from the pGenesil-1 vector, and ligated into pLV-mCMV-ZsGreen-PGK-puro shuttle vector, which was called pLV-SNAIL shRNA. Plasmids were purified with a MaxPrep kit and successful ligations were verified by sequencing (Sango, China). Recombinant lentiviral vectors were produced by co-transfecting HEK-293T cells with the lentiviral expression plasmid and packaging plasmids using the calcium phosphate method. Briefly, 8 µg shRNA plasmid DNA, 5 µg lentiviral helper1 and 6 µg lentiviral helper 2 plasmids were mixed with sterile ddH 2 O to a final volume of 450 µl and mixed with 50 µl of 2.5 M CaCl 2 . After transfection, infectious media, containing shRNA lentiviral vectors, were harvested at 48 and 72 h.
Construction and production of lentiviral vectors
Cell culture and infection. The human hepatocellular cancer HepG2 cell line and HEK293T cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were grown in 5% CO 2 at a saturated humidity, at 37˚C and cultured as a monolayer in RPMI-1640 medium supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin, 2 mmol/l glutamine and 10% FBS.
HepG2 cells were passaged to 40% confluence the following day. The viral media were added to HepG2 cells with 8 µg/ml Polybrene 4 times over two days. After infection for 72 h, viral media were removed and cells were collected for further experiments.
Cell proliferation assay. Cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. HepG2 cells (the LV-SNAIL siRNA, LV-nonsense RNA and parental cell groups) were seeded in 96-well plates in culture medium at an optimal density (5x10 3 cells/well) in triplicate wells. After growing for 12, 24 and 48 h, 20 µl of 5 mg/ml MTT (in PBS) was added to each well and continually incubated for 4 h at 37˚C in a CO 2 incubator. The formazan granules obtained from the cells were dissolved in 150 µl dimethyl sulfoxide (DMSO) for 10 min. Cell viability was then measured in terms of the optical density (OD) at a wavelength of 490 nm. Each cell viability assay was performed and repeated three times. Quantification by real-time PCR. Transfected and untreated cells were collected and washed with phosphate-buffered saline (PBS). Total RNA was extracted from the cells of the three groups, and cDNA was generated with a PrimeScript ® RT reagent kit (Takara, Chiga, Japan) at a total volume of 20 µl according to the manufacturer's instructions. cDNA was then used in each amplification reaction. Reactions were performed using the SYBR ® Premix Ex Taq™ (Takara), under the following PCR conditions: 95˚C for 30 sec, followed by 40 cycles of 95˚C for 5 sec and 60˚C for 30 sec. Each sample was also subjected to melting curve analysis to confirm amplification specificity. GAPDH was used as a control housekeeping gene. The expression of SNAIL was assessed by normalization of the cycle threshold (Ct) of these genes to that of GAPDH. A Ct value was obtained from each amplification curve by using the software provided by the manufacturer (Roche, Mannheim, Germany).
Western blot analysis. Cell lysates of the lentiviral-infected HepG2 cell clones and the non-transfected HepG2 cell controls were harvested and subjected to SDS-PAGE in 10% polyacrylamide gel. Bands were probed for SNAIL protein expression using rabbit polyclonal anti-SNAIL and secondary goat anti-rabbit alkaline phosphatase antibody (Abcam, Cambridge, MA, USA). GAPDH detection was performed using rabbit polyclonal anti-GAPDH and mouse monoclonal anti-GAPDH (Abcam). Blots were incubated with appropriate HRP-conjugated secondary antibodies and specific binding was detected by ECL (Pierce, Rockford, IL, USA).
Results

Selection of the most effective SNAIL-specific shRNA.
Expression levels of SNAIL mRNA and protein in the HepG2 cell line were detected in previously published data by our laboratory (19) . The levels of SNAIL mRNA and protein were were previously found to be increased in metastatic tumor samples in comparison to non-metastatic tumor samples and the same phenomena were detected in HepG2 cells (19) . We determined the effects of SNAIL inhibition on the viability and growth of HepG2 cells. For screening the most effective shRNA fragment, three plasmids containing shSNAIL (pGenesil-SNAIL shRNA) were constructed and transfected into HepG2 cells using the Lipofectamine 2000 reagent, respectively. GFP expression in the HepG2 cells was observed under a fluorescence microscope 36 h after transfection with the pGenesil vectors. Results of the western blot assay showed that pGenesil-SNAIL shRNA2 significantly suppressed the expression of SNAIL at the protein level in HepG2 cells, while real-time PCR determined expression at the mRNA level. According to the results of the real-time PCR and western blot assay, SNAIL shRNA2 was the most effective and, thus, was used in the subsequent experiments (Fig. 2) .
Construction and analysis of the LV-SNAIL shRNA.
The most efficient shRNA expression cassette was selected and constructed into the lentiviral vector, named LV-SNAIL shRNA. To determine the effect of LV-SNAIL shRNA on the expression of SNAIL, GFP expression was observed under a fluorescence microscope in the HepG2 cells 72 h after infection with LV-SNAIL shRNA and LV-CONTROL-GFP (Fig. 3) . Next, real-time PCR and western blotting were performed to determine the mRNA and protein levels of SNAIL in the LV-SNAIL shRNA, LV-CONTROL-GFP and parental cell groups. As shown in Fig. 4 , LV-SNAIL shRNA significantly inhibited expression of SNAIL protein when compared with the levels in the HepG2 cells and the LV-CONTROL-GFP group. Cell proliferation analysis in HepG2 cells. Cell proliferation was monitored for 4 days after HepG2 cells were infected with LV-SNAIL shRNA, LV-CONTROL-GFP and in parental cells without infection. MTT assay was used to evaluate cell viability. The absorption value at 490 nm was determined. As a result, we found that transfection with LV-CONTROL-GFP had no effect on the cell proliferation and viability in the cell groups (Fig. 5) while transfection with LV-SNAIL shRNA caused a dramatic reduction in proliferation when compared with the proliferation rate in the parental HepG2 cells.
E-cadherin expression assay. As shown in Fig. 6 , E-cadherin protein expression was evaluated by western blotting in the human HepG2 cell lines. Silencing of SNAIL expression by LV-SNAIL shRNA significantly increased the expression of E-cadherin when compared with the LV-SNAIL shRNA and parent groups. LV-SNAIL shRNA markedly downregulated the protein level of SNAIL and upregulated the protein level of E-cadherin in HepG2 cells when compared with these levels in the other two cell groups.
Discussion
The SNAIL signaling pathway plays a significant role in various physiological processes, including cell growth, cell cycle regulation (20) and embryonic development (15) . However, SNAIL has been implicated in cell proliferation, invasion and metastasis in a diverse group of human cancers, including liver cancer. Recent studies have also revealed that the promotion of SNAIL activation contributes to oncogenesis and the invasion and metastasis of cancers (21,22) . Thus, the purpose of the present study was to assess the changes in the mRNA and protein expression of SNAIL and E-cadherin involved in EMT in HepG2 cell lines.
Epithelial to mesenchymal transition (EMT), which converts epithelial cells into migratory mesenchymal cells, is crucial for embryonic development. It is characterized by upregulation of extracellular matrix components, loss of intercellular cohesion, increased rate of cellular migration and invasion, as well as increased resistance to apoptosis. Recently, EMT has emerged as a pivotal event in the development of the invasive and metastatic potential associated with cancer progression (7) . This type of transition occurs through a decrease in E-cadherin expression and gain of vimentin expression, leading to increased cell migration, invasion and tumorigenicity (8) . Downregulation of E-cadherin is a major event in EMT. E-cadherin, which is a key cadherin, plays a major role in the establishment and maintenance of intercellular adhesion, cell polarity and tissue architecture (9) . At present, there is substantial evidence that functional perturbation of E-cadherin expression during the process of EMT occurs at the transcriptional level. According to various studies, numerous transcription factors have been associated with regulation of EMT, including SNAIL (10), Zeb1 (11), Zeb (2), Twist1 (12) and Slug (13) . Among these regulators, SNAIL is a prominent inducer of EMT which strongly suppresses E-cadherin expression (14) .
In order to elucidate the role played by SNAIL in HCC, we suppressed SNAIL in HCC cells using the RNAi method by a lentiviral vector. RNAi is the process by which double-strand RNA induces potent and specific inhibition of eukaryotic gene expression through the degradation of complementary messenger RNA, and is functionally similar to the process of post-transcriptional gene silencing. The inhibitory potency and the method of transferring siRNA into HCC cells are two critical factors for successful application of the RNAi method. In recent years, shRNAs have been proven to provide longlasting silencing and maximal inhibition of gene expression at lower concentration (23) . However, the inhibitory potency of shRNA is related to specificity of the target sequence, thus we used three pairs of shRNAs for screening the most effective downregulated gene fragment. Thus, we chose SNAIL siRNA2 which was able to knock out the expression of SNAIL efficiently. In addition, in order to identify the target gene or the vector fragment, we used EGFP siRNA as the control group and parental cells as the blank group. In the present study, we found that LV-SNAIL siRNA2 suppressed the expression of SNAIL at both the mRNA and protein levels in HCC. In the control group of HepG2 cells, however, the expression SNAIL was significantly increased compared with the experimental group. We concluded that LV-shSNAIL had a high specificity for SNAIL.
In the present study, a lentiviral vector was selected as our shRNA delivery vehicle since lentiviruses can transfect both dividing and non-dividing cells at a high efficiency and sustain long-term gene expression by integration into the host genome. What is more, lentiviral vectors are safe for use in humans, and they have the potential to become the means for human gene therapy. At present, an increasing number of studies suggest that activation of SNAIL plays an important role in the early metastasis of carcinomas (24) . Furthermore, disruption of SNAIL expression has been reported to suppress cell metastasis by decreasing EMT and increasing epitheliumspecific genes, such as E-cadherin in other carcinomas (25) . In our study, the expression of SNAIL and E-cadherin exhibited a negative correlation, which may be another major verification for our findings. Thus, our results indicate that blocking SNAIL expression upregulates E-cadherin expression directly or indirectly in HepG2 cells.
An increasing number of studies suggest that activation of SNAIL plays an important role in many carcinomas (26, 27) . Furthermore, disruption of SNAIL at the transcriptional level has been reported to suppress cell invasion by decreasing cell-cell homotypic adhesion and increasing cell motility (14) . Moreover, inappropriate and constitutive activation of SNAIL may be responsible for HCC progression by regulating expression of target genes, such as cadherin and MMP-2 (9) . In the present study, the survival of cells using a cell proliferation analysis was examined and we found that silencing of SNAIL by RNAi in HepG2 cells resulted in reduced proliferation and survival. Conversely, the expression of E-cadherin in the SNAIL-silenced cell group was upregulated, which indicates that the reduced proliferation and survival which resulted from the silencing of SNAIL by RNAi was caused by the upregulation of the expression of E-cadherin.
Overall, our study indicates that siRNA targeting of SNAIL mRNA via a lentiviral vector system effectively sustains knockdown of the SNAIL gene expression in HepG2 cells. In the present study, we describe the successful construction of a lentiviral RNAi vector targeting SNAIL that may provide a useful tool with which to study the function of the SNAIL gene in liver cancer cells. Our findings strongly suggest that SNAIL and E-cadherin play a significant role in HCC progression, and exhibit a negative correlation. Furthermore, the expression of E-cadherin may be responsible for the reduced proliferation and survival of HepG2 cells. Targeting SNAIL activation may prove to be an effective approach for controlling HCC progression. Thus, the SNAIL signaling pathway may provide a novel therapeutic target for the treatment of HCC.
